Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 128-140

  Szeto, Carol Ying Ying ^a   Lin, Chi Ho ^a   Choi, Siu Chung ^a   Yip, Timothy T C ^a,b   Ngan, Roger Kai Cheong ^a,b   Tsao, George Sai Wah ^a   Li Lung, Maria ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Nasopharyngeal carcinoma; Nasopharyngeal cell lines xenograft (NP460, HK1, C666, X666); RNA sequencing; TP53; Transcriptome analysis

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MICRORNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INDEL MUTATION; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA SEQUENCE; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; EPSTEIN BARR VIRUS; GENE DELETION; GENE INSERTION; IN VITRO STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; TUMOR XENOGRAFT;

EID: 84892876422     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.01.004     Document Type: Article

References (86)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 127:2893-2917.
2. Boyle, P. and Levin, B. (2008) World cancer report 2008.
3. Marks J.E., Phillips J.L., Menck H.R. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998, 83:582-588.
4. Smerq J., Sharma M. The risk factor: nasopharyngeal carcinoma. Int. J. Pharm. Clin. Res. 2011, 3:48-51.
5. Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., Armand J.P. Nasopharyngeal carcinomas: an update. Eur. J. Cancer 2003, 39:2121-2135.
6. Cheung S.T., Huang D.P., Hui A.B., Lo K.W., Ko C.W., Tsang Y.S., Wong N., Whitney B.M., Lee J.C. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 1999, 83:121-126.
7. Glaser R., Zhang H.Y., Yao K.T., Zhu H.C., Wang F.X., Li G.Y., Wen D.S., Li Y.P. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc. Natl. Acad. Sci. USA 1989, 86:9524-9528.
8. Huang D.P., Ho J.H., Poon Y.F., Chew E.C., Saw D., Lui M., Li C.L., Mak L.S., Lai S.H., Lau W.H. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int. J. Cancer 1980, 26:127-132.
9. Zhang S., Wu Y., Zeng Y., Zech L., Klein G. Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas 1982, 97:23-28.
10. Li H.M., Man C., Jin Y., Deng W., Yip Y.L., Feng H.C., Cheung Y.C., Lo K.W., Meltzer P.S., Wu Z.G., Kwong Y.L., Yuen A.P., Tsao S.W. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int. J. Cancer 2006, 119:1567-1576.
11. Busson P., Ganem G., Flores P., Mugneret F., Clausse B., Caillou B., Braham K., Wakasugi H., Lipinski M., Tursz T. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer 1988, 42:599-606.
12. Huang D.P., Ho J.H., Chan W.K., Lau W.H., Lui M. Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chin. Int. J. Cancer 1989, 43:936-939.
13. Huang D.P., Ng H.K., Ho Y.H., Chan K.M. Epstein-Barr virus (EBV)-associated undifferentiated carcinoma of the parotid gland. Histopathology 1988, 13:509-517.
14. Rodriguez S., Khabir A., Keryer C., Perrot C., Drira M., Ghorbel A., Jlidi R., Bernheim A., Valent A., Busson P. Conventional and array-based comparative genomic hybridization analysis of nasopharyngeal carcinomas from the Mediterranean area. Cancer Genet. Cytogenet. 2005, 157:140-147.
15. Marioni J.C., Mason C.E., Mane S.M., Stephens M., Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18:1509-1517.
16. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
17. Liu X., Lv X.B., Wang X.P., Sang Y., Xu S., Hu K., Wu M., Liang Y., Liu P., Tang J., Lu W.H., Feng Q.S., Chen L.Z., Qian C.N., Bei J.X., Kang T., Zeng Y.X. MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 2012, 11:2495-2506.
18. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Dahl D.B., Chen M., Cheng Y.J., Westra W.H., Chen C.J., Hildesheim A., Sugden B., Ahlquist P. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 2006, 66:7999-8006.
19. Xia H., Ng S.S., Jiang S., Cheung W.K., Sze J., Bian X.W., Kung H.F., Lin M.C. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem. Biophys. Res. Commun. 2010, 391:535-541.
20. Zhang L., Deng T., Li X., Liu H., Zhou H., Ma J., Wu M., Zhou M., Shen S., Niu Z., Zhang W., Shi L., Xiang B., Lu J., Wang L., Li D., Tang H., Li G. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010, 31:559-566.
21. Arvey A., Tempera I., Tsai K., Chen H.S., Tikhmyanova N., Klichinsky M., Leslie C., Lieberman P.M. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 2012, 12:233-245.
22. Vereide D.T., Seto E., Chiu Y.F., Hayes M., Tagawa T., Grundhoff A., Hammerschmidt W., Sugden B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 2013.
23. Lung R.W., Tong J.H., Sung Y.M., Leung P.S., Ng D.C., Chau S.L., Chan A.W., Ng E.K., Lo K.W., To K.F. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11:1174-1184.
24. Lei T., Yuen K.S., Xu R., Tsao S.W., Chen H., Li M., Kok K.H., Jin D.Y. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int. J. Cancer 2012.
25. Chen H.C., Chen G.H., Chen Y.H., Liao W.L., Liu C.Y., Chang K.P., Chang Y.S., Chen S.J. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 2009, 100:1002-1011.
26. Chen S.J., Chen G.H., Chen Y.H., Liu C.Y., Chang K.P., Chang Y.S., Chen H.C. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 2010, 5.
27. Wong A.M., Kong K.L., Tsang J.W., Kwong D.L., Guan X.Y. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2012, 118:698-710.
28. Neilsen C.T., Goodall G.J., Bracken C.P. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012, 28:544-549.
29. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., Lee J.C., Hjelm N.M., Johnson P.J., Huang D.P. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999, 59:1188-1191.
30. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
31. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
32. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 2004, 32:D109-111.
33. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-144.
34. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-158.
35. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-157.
36. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
37. Kertesz M., Iovino N., Unnerstall U., Gaul U., Segal E. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39:1278-1284.
38. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-153.
39. Croft D., O'Kelly G., Wu G., Haw R., Gillespie M., Matthews L., Caudy M., Garapati P., Gopinath G., Jassal B., Jupe S., Kalatskaya I., Mahajan S., May B., Ndegwa N., Schmidt E., Shamovsky V., Yung C., Birney E., Hermjakob H., D'Eustachio P., Stein L. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 2011, 39:D691-697.
40. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., Christmas R., Avila-Campilo I., Creech M., Gross B., Hanspers K., Isserlin R., Kelley R., Killcoyne S., Lotia S., Maere S., Morris J., Ono K., Pavlovic V., Pico A.R., Vailaya A., Wang P.L., Adler A., Conklin B.R., Hood L., Kuiper M., Sander C., Schmulevich I., Schwikowski B., Warner G.J., Ideker T., Bader G.D. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2:2366-2382.
41. Koboldt D.C., Zhang Q., Larson D.E., Shen D., McLellan M.D., Lin L., Miller C.A., Mardis E.R., Ding L., Wilson R.K. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012, 22:568-576.
42. Wang K., Li M., Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38:e164.
43. Crooks G.E., Hon G., Chandonia J.M., Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 2004, 14:1188-1190.
44. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010, 11:R106.
45. Wang X., Kang D.D., Shen K., Song C., Lu S., Chang L.C., Liao S.G., Huo Z., Tang S., Ding Y., Kaminski N., Sibille E., Lin Y., Li J., Tseng G.C. An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics 2012, 28:2534-2536.
46. Untergasser A., Nijveen H., Rao X., Bisseling T., Geurts R., Leunissen J.A. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 2007, 35:W71-74.
47. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999, 270:41-49.
48. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
49. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., Jia M., Shepherd R., Leung K., Menzies A., Teague J.W., Campbell P.J., Stratton M.R., Futreal P.A. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011, 39:D945-950.
50. Chen K., Song F., Calin G.A., Wei Q., Hao X., Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008, 29:1306-1311.
51. Bose S., Yap L.F., Fung M., Starzcynski J., Saleh A., Morgan S., Dawson C., Chukwuma M.B., Maina E., Buettner M., Wei W., Arrand J., Lim P.V., Young L.S., Teo S.H., Stankovic T., Woodman C.B., Murray P.G. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J. Pathol. 2009, 217:345-352.
52. Hu C., Wei W., Chen X., Woodman C.B., Yao Y., Nicholls J.M., Joab I., Sihota S.K., Shao J.Y., Derkaoui K.D., Amari A., Maloney S.L., Bell A.I., Murray P.G., Dawson C.W., Young L.S., Arrand J.R. A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PLoS One 2012, 7:e41055.
53. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
54. Chan K.C., Ko J.M., Lung H.L., Sedlacek R., Zhang Z.F., Luo D.Z., Feng Z.B., Chen S., Chen H., Chan K.W., Tsao S.W., Chua D.T., Zabarovsky E.R., Stanbridge E.J., Lung M.L. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int. J. Cancer 2011, 129:1826-1837.
55. Chen H., Ko J.M., Wong V.C., Hyytiainen M., Keski-Oja J., Chua D., Nicholls J.M., Cheung F.M., Lee A.W., Kwong D.L., Chiu P.M., Zabarovsky E.R., Tsao S.W., Tao Q., Kan R., Chan S.H., Stanbridge E.J., Lung M.L. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. Cancer Lett. 2012, 325:89-98.
56. Law E.W., Cheung A.K., Kashuba V.I., Pavlova T.V., Zabarovsky E.R., Lung H.L., Cheng Y., Chua D., Lai-Wan Kwong D., Tsao S.W., Sasaki T., Stanbridge E.J., Lung M.L. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene 2012, 31:728-738.
57. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., Chen C.J., Hildesheim A., Sugden B., Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. USA 2008, 105:5874-5878.
58. Pedrero J.M., Carracedo D.G., Pinto C.M., Zapatero A.H., Rodrigo J.P., Nieto C.S., Gonzalez M.V. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int. J. Cancer 2005, 114:242-248.
59. Yip W.K., Leong V.C., Abdullah M.A., Yusoff S., Seow H.F. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol. Rep. 2008, 19:319-328.
60. Adam L., Zhong M., Choi W., Qi W., Nicoloso M., Arora A., Calin G., Wang H., Siefker-Radtke A., McConkey D., Bar-Eli M., Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin. Cancer Res. 2009, 15:5060-5072.
61. Lo A.K., Dawson C.W., Jin D.Y., Lo K.W. The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J. Pathol. 2012, 227:392-403.
62. Kim K.H., Seol H.J., Kim E.H., Rheey J., Jin H.J., Lee Y., Joo K.M., Lee J., Nam D.H. Wnt/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol. 2013, 15:161-171.
63. Morris L.G., Kaufman A.M., Gong Y., Ramaswami D., Walsh L.A., Turcan S., Eng S., Kannan K., Zou Y., Peng L., Banuchi V.E., Paty P., Zeng Z., Vakiani E., Solit D., Singh B., Ganly I., Liau L., Cloughesy T.C., Mischel P.S., Mellinghoff I.K., Chan T.A. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat. Genet. 2013.
64. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19:3159-3167.
65. Zhao F., Xuan Z., Liu L., Zhang M.Q. TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res. 2005, 33:D103-107.
66. Sung F.L., Poon T.C., Hui E.P., Ma B.B., Liong E., To K.F., Huang D.P., Chan A.T. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells. In Vivo 2005, 19:237-245.
67. Forget M.A., Turcotte S., Beauseigle D., Godin-Ethier J., Pelletier S., Martin J., Tanguay S., Lapointe R. The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br. J. Cancer 2007, 96:646-653.
68. Yamabuki T., Takano A., Hayama S., Ishikawa N., Kato T., Miyamoto M., Ito T., Ito H., Miyagi Y., Nakayama H., Fujita M., Hosokawa M., Tsuchiya E., Kohno N., Kondo S., Nakamura Y., Daigo Y. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 2007, 67:2517-2525.
69. Hall C.L., Daignault S.D., Shah R.B., Pienta K.J., Keller E.T. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate 2008, 68:1396-1404.
70. LeibundGut-Landmann S., Waldburger J.M., Krawczyk M., Otten L.A., Suter T., Fontana A., Acha-Orbea H., Reith W. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol 2004, 34:1513-1525.
71. Yao Y., Minter H.A., Chen X., Reynolds G.M., Bromley M., Arrand J.R. Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer 2000, 88:949-955.
72. Hsieh E.H., Fernandez X., Wang J., Hamer M., Calvillo S., Croft M., Kwon B.S., Lo D.D. CD137 is required for M cell functional maturation but not lineage commitment. Am. J. Pathol 2010, 177:666-676.
73. Kraehenbuhl J.P., Neutra M.R. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 2000, 16:301-332.
74. Dinarello C.A. The paradox of pro-inflammatory cytokines in cancer. Cancer Metastasis Rev. 2006, 25:307-313.
75. Hu H., Tang K.F., Chua Y.N., Lu J., Feng P., Chew C.T., Chan S.H. Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration. Hum. Pathol. 2004, 35:722-728.
76. Leroy B., Fournier J.L., Ishioka C., Monti P., Inga A., Fronza G., Soussi T. The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. Nucleic Acids Res. 2013, 41:D962-969.
77. Kato S., Han S.Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl. Acad. Sci. USA 2003, 100:8424-8429.
78. Shiraishi K., Kato S., Han S.Y., Liu W., Otsuka K., Sakayori M., Ishida T., Takeda M., Kanamaru R., Ohuchi N., Ishioka C. Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J. Biol. Chem. 2004, 279:348-355.
79. Sheu L.F., Chen A., Tseng H.H., Leu F.J., Lin J.K., Ho K.C., Meng C.L. Assessment of p53 expression in nasopharyngeal carcinoma. Hum. Pathol. 1995, 26:380-386.
80. Zhuo X.L., Cai L., Xiang Z.L., Zhuo W.L., Wang Y., Zhang X.Y. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Arch. Med. Res. 2009, 40:299-305.
81. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998, 19:275-280.
82. Guo X., Zeng Y., Deng H., Liao J., Zheng Y., Li J., Kessing B., O'Brien S.J. Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of nasopharyngeal carcinoma in a Han Chinese population of Southern China. BMC Res. Notes 2010, 3:212.
83. Townsend D.M., Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003, 22:7369-7375.
84. Cloonan N., Wani S., Xu Q., Gu J., Lea K., Heater S., Barbacioru C., Steptoe A.L., Martin H.C., Nourbakhsh E., Krishnan K., Gardiner B., Wang X., Nones K., Steen J.A., Matigian N.A., Wood D.L., Kassahn K.S., Waddell N., Shepherd J., Lee C., Ichikawa J., McKernan K., Bramlett K., Kuersten S., Grimmond S.M. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 2011, 12:R126.
85. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83:2357-2367.
86. Chen L., Li Y., Lin C.H., Chan T.H., Chow R.K., Song Y., Liu M., Yuan Y.F., Fu L., Kong K.L., Qi L., Li Y., Zhang N., Tong A.H., Kwong D.L., Man K., Lo C.M., Lok S., Tenen D.G., Guan X.Y. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 2013, 19:209-216.